| INTRODUC TI ON
Cellular senescence is a complex phenotype observed in diverse tissues at distinct developmental stages (He & Sharpless, 2017) . In adults, senescence likely acts to irreversibly prevent proliferation of damaged cells (Chen et al., 2005; Cosme-Blanco et al., 2007; Feldser & Greider, 2007) . Senescent cells appear during chronological aging, aberrant oncogene expression, and exposure to DNA damaging agents (Bartkova et al., 2006; Chen, Fischer, Reagan, Yan, & Ames, 1995) . Without a universal marker, identification of senescent cells in tissues remains challenging. Expression of the tumor suppressor p16
INK4a increases with age in numerous mouse and human tissues and, thus, considered a reliable marker (Krishnamurthy et al., 2004) . Exposure to ionizing radiation (IR) leads to delayed increase in p16 INK4a expression in mice tissues and cancer-treated patients (Le et al., 2010; Marcoux et al., 2013; Sanoff et al., 2014) .
Senescent cells accumulate in tissues and secrete a range of cytokines, chemokines, and proteases known as the senescence-associated secretory phenotype (SASP) (Coppe et al., 2008; Kuilman et al., 2008) . Why senescent cells accumulate in vivo remains unclear. One theory suggests senescence accumulates with a decline in immune functions with age. Several studies indicate senescent cell immune clearance in liver and tumorigenic tissues (Kang et al., 2011; Sagiv et al., 2013; Toso et al., 2014; Xue et al., 2007) . While senescent cells support wound healing, accumulation of senescent cells also appears to contribute to tumor growth and development of age-associated diseases (Coppe, Kauser, Campisi, & Beausejour, 2006; Krtolica, Parrinello, Lockett, Desprez, & Campisi, 2001; Oubaha et al., 2016) . Significantly, genetic or pharmacological elimination of senescent cells reverses the onset of aging and associated pathologies in mice (Baker et al., 2016; Farr et al., 2017; Jeon et al., 2017; Ogrodnik et al., 2017; Schafer et al., 2017) . Removing senescent cells reduces some side effects of chemotherapy and mitigate IR-induced premature aging in murine hematopoietic stem cells (Chang et al., 2016; Demaria et al., 2017 ).
Substantial data demonstrate the impact of aging on the immune system promotes increased susceptibility to infection (Haynes & Swain, 2012; Kogut, Scholz, Cancro, & Cambier, 2012; Liu et al., 2011; Nikolich-Zugich, 2014) . Several groups demonstrate aged individuals exhibit attenuated immune adaptive response, particularly reduced proliferation of T cells and dendritic cell function (You, Dong, Mann, Knight, & Yaqoob, 2014) . Deletion of p16 INK4a in T cells enhanced antigen-specific immune response, which suggest senescence promotes an intrinsic defect in aged T cells (Liu et al., 2011) . Moreover, mice lacking the expression of lamin A, a nuclear scaffolding protein, present an accelerated aging phenotype with immune deficiencies (Xin, Jiang, Kinder, Ertelt, & Way, 2015) . In comparison, whether IR-induced senescence has a long-term impact on the immune system is less defined. A recent study showed mice irradiated (up to 4 Gy) at a young age failed to impair immune functions at old age (Pugh et al., 2016) . Of note, the study compared irradiated aged mice (19 months) with 
| RE SULTS

| Exposure to IR induces features of senescence in the spleen
We previously showed that exposure to IR led to delayed (6-8 weeks) p16 INK4a expression in distinct mice tissues, including the spleen (Le et al., 2010; Palacio, Krishnan, Le, Sharpless, & Beausejour, 2017) .
The cause for expression delay remains unclear but it protects mice against cancer progression (Palacio et al., 2017) . To answer these questions, we first exposed mice to total body irradiation at a sublethal dose of 6.5 Gy, the maximum tolerated dose for mice to survive without requiring a bone marrow transplant ( Figure 1a) . Figure S1A and B). Furthermore, we detected persistent DNA damage in stromal splenic cells, which did not appear in macrophages and hematopoietic cells ( Figure S1C and D). Of note, splenic cell counts never completely reached levels observed prior to irradiation ( Figure S2 ).
We used p16-3MR mice, in which p16 INK4a -positive cells are visualized and eliminated upon the administration of coelenterazine and ganciclovir (GCV), respectively (Demaria et al., 2014) . Using luminescence reporter activity and qPCR data, we found p16 
| Attrition of CD3
+ and B220 + cell populations in the irradiated spleen A few days following IR, we detected substantial cell death in splenic T and B cells which also occurred in other cell populations to a lesser extent (Figures S2 and S3) . A result consistent with the fact that lymphocytes constitute a highly radiosensitive cell population. We asked whether IR induced p16 INK4a in lymphocytes and whether this impacted their absolute number after reconstitution. We collected spleens from control, irradiated mice untreated/treated with GCV and dissociated at the single-cell level. We isolated cell populations with magnetic columns (~90% purity as determined by flow cytometry) and extracted mRNA for qPCR analysis. We found p16 INK4a gene expression elevated fourfold in F I G U R E 3 IR impairs T-cell proliferation in vitro and in vivo. (a) Schematic of the experimental design. 12-week-old p16-3MR mice were exposed to 6.5 Gy total body irradiation, and 8-9 weeks later, mice were treated or not with GCV for 5 consecutive days. On day 6 (D6), mice were sacrificed and splenocytes were collected and labeled with CFSE. Alternatively, on day 15 (D15), mice were injected with the LCMV-Arm and sacrificed 1 week later. mice except for panels d and e where each dot represents counts from an individual mouse. The ρ value was determined by a one-way ANOVA, ***p < 0.001; **p < 0.01; *p < 0.05
CD3 + cells and fivefold in B220 + cells (Figure 2a, b) . These levels are similar to data from aged spleen-derived lymphocytes (Krishnamurthy et al., 2004 
| Impaired proliferation of T cells depends on the irradiated splenic environment
We next and freshly irradiated allogenic splenocytes obtained from a CD-1 mouse. A one-way MLR relies on the ability of "responder" cell (i.e., T cells within p16-3MR splenocytes) activation by allogenic HLA molecules displayed by "stimulator" cells (i.e., antigen-presenting cells in allogenic CD-1 splenocytes). The one-way MLR allowed us to restrict irradiated allogenic splenocytes to act as stimulators but not responders. Splenic T cells from p16-3MR mice irradiated 8-9 weeks earlier exhibit approximately 40% reduced proliferation compared to splenic T cells from nonirradiated mice (~65%-70% vs.
~35%-40%, see Figure 3b ). Significantly, the proliferation of splenic T cells was restored in irradiated mice treated with GVC (Figure 3b ).
In contrast, magnetically purified T cells (not full splenocytes) did not demonstrate improved proliferative capacity (Figure 3c ). Overall, these results demonstrate that IR does not impair intrinsic proliferation of splenic T cells. Irradiated splenocytes appear to compromise T-cell proliferation in vitro and in vivo which suggests the splenic environment, either cells or their secretome, interferes with T-cell proliferation. To test this notion, we performed a MLR with CD3 + effector T cells purified from p16-3MR mice and stimulator cells from freshly irradiated CD-1 splenocytes. We placed effector and stimulator cells in the presence of an "environment" of CD3 + -depleted splenocytes isolated from p16-3MR mice (Figure 4a ).
This experimental setup confirmed that the presence of a previously (8-9 weeks) irradiated splenic environment compromised the proliferative capacity of purified T cells (Figure 4b ). Additionally, we partially restored T cell proliferation when we used splenic environment from GCV-treated mice with GCV ( Figure 4b ).
To identify whether irradiated splenocytes or their secretome proved detrimental to T cell proliferation, we performed a modified MLR whereby we separated effector/stimulator cells from splenocytes using a transwell. Thus, preventing cellular interaction allowed us to determine whether the splenic environment (secretome) effectively interfered with proliferation. Using beads coupled to anti-CD3 and anti-CD28 antibodies as stimulator, we found that delay in T cell proliferation only required exposure to irradiated splenocyte secretome (Figure 4c,d) . We confirmed the negative impact of irradiated secretome on T cell proliferation, testing allogenic splenocytes 
| IR impairs macrophages and dendritic cells in the spleen
Macrophages and dendritic cells (DC) play a pivotal role in innate and adaptive immunity through their capacity to phagocyte, process, and present antigens. These cells exhibit more radioresistance than lymphocytes 1 week following exposure to IR ( Figure   S2 and S3 Whether a decrease in phagocytosis is sufficient to negatively impact T cell proliferation in the context of a MLR requires more study.
We also observe a slight increase in the number of macrophages following the injection of GCV in irradiated mice, an unexpected result given the high level of p16 INK4a expression in this population.
We speculate the increase may result from peripheral macrophages recruited to the spleen in response to GCV-induced cell death.
Recent data demonstrate immune stimuli modulate the expression of p16 INK4a in macrophages, suggesting a complex regulation in these cells and more work required to delineate complex regulation (Hall et al., 2017) .
Studies in aging mice and humans show an increase in the proportion of regulatory T cells (T regs) that impair immune function (Sharma, Dominguez, & Lustgarten, 2006; Simone, Zicca, & Saverino, 2008) . We quantified the proportion of T regs in the spleen and found their number sharply decreased in irradiated mice (with and without treatment with GCV), suggesting these cells are unlikely to negatively impact proliferation of T cells ( Figure S5 ). Finally, IR may act on the stromal architecture of the spleen stroma. Indeed, we observe a significant increase in p16 INK4a expression and decrease in absolute cell counts following the injection of GCV in sub-populations (gp38 + and CD35 + ) of splenic stromal cells ( Figure S6 ). Hence, while we show that the SASP negatively affects proliferation of splenic T cells, the overall impact of IR on the spleen function may alter multiple signaling pathways and is likely multifactorial.
In conclusion, we demonstrate that elimination of p16 
| MATERIAL S AND ME THODS
| Animals and treatments
p16-3MR mice were kindly donated by Dr. Judith Campisi (Buck Institute) and breed on site according to a material transfer agreement (Demaria et al., 2014) . All in vivo manipulations were approved by the Comité Institutionnel des Bonnes Pratiques Animales en
Recherche of the CHU Ste-Justine. 12-to 14-week-old p16 INK4a -3MR mice were exposed to X-rays at the single sublethal dose of 6.5 Gy (1 Gy/min) using a Faxitron CP-160. GCV was administrated daily by intraperitoneal (i.p.) injections for 5 consecutive days at a dose of 25 mg/kg in 1X-PBS (Sigma). 
| Viral infection
| Bioluminescence
To detect luminescence from the 3MR gene cassette, mice were anesthetized using isoflurane and injected i. 
| Gene expression
RNA was extracted from spleens and from isolated CD3 
| Flow cytometric analysis
To obtain absolute cell counts from various populations, spleens were 
| In vitro phagocytosis assay
| Multiplex cytokine analysis
The splenic cell secretome was quantified by Eve Technologies allogenic CD-1 splenocytes at a proportion of 1:2. Where indicated, the proliferation of p16-3MR CFSE-labeled CD3 + responder cells was also induced using the Dynabeads ® mouse T-activator CD3/CD28 system (11456D, Fisher).
| Statistical analysis
GraphPad Prism 7 software was used for statistical analysis; ρ values on multiple comparisons were calculated using one-way analysis of variance (ANOVA) with Bonferroni post hoc test.
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